Skip to content

Firm News

Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma Inc. in $2.46 Million Registered Direct Offering

April 8, 2025

Q1 2025 Recap: Sichenzia Ross Ference Carmel Closes 45 Capital Markets Transactions Valued at Over $500 Million; Adds Managing Partner; and Continues its Ascent Among Securities Law Firm Ranks

April 8, 2025

Sichenzia Ross Ference Carmel LLP Represents MKDWELL Tech Inc. in $10 Million Private Placement Offering

April 7, 2025

Sichenzia Ross Ference Carmel LLP Represents Soulpower Acquisition Corporation in $220 Million Upsized Initial Public Offering

April 2, 2025

Sichenzia Ross Ference Carmel LLP Represents Calidi Biotherapeutics, Inc. in $3.9 Million Registered Direct Offering and Concurrent Private Placement

April 1, 2025

Founding Partner Gregory Sichenzia Featured in Law360 Article About Nasdaq’s Tighter IPO Rules

April 1, 2025

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $8.15 Million Registered Direct Offering of authID

March 31, 2025

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in the Direct Listing of NeOnc Technologies Holdings to Nasdaq

March 27, 2025

Sichenzia Ross Ference Carmel LLP Represents an Institutional Investor in the $1 Million Registered Direct Offering of IntChains Group

March 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Tenon Medical in $2.5 Million Registered Direct Offering

March 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Tenon Medical in $1.5 Million Registered Direct Offering

March 25, 2025

Sichenzia Ross Ference Carmel LLP Represents PMGC Holdings Inc. in $1.48 Million Registered Direct Offering

March 25, 2025

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $2.7 Million Registered Direct Offering of Spectral AI

March 24, 2025

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $2.5 Million Public Offering of CEL-SCI Corporation

March 19, 2025

Sichenzia Ross Ference Carmel Names Evan Cappelli as its Corporate and Securities Department Managing Partner

March 18, 2025

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $15 Million Private Placement Offering of Plus Therapeutics

March 4, 2025

Sichenzia Ross Ference Carmel LLP Represents Healthcare Triangle in $15.2 Million PIPE Offering

February 27, 2025

Sichenzia Ross Ference Carmel LLP Represents Basel Medical Group Ltd In $8,820,000 Initial Public Offering

February 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management in $600,000 Public Offering of Intelligent Living Application Group

February 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Siyata Mobile in Definitive Merger Agreement with Core Gaming

February 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Aspire Biopharma Holdings Inc. in De-SPAC Transaction, Nasdaq Listing, and $3 Million Securities Purchase Agreement

February 25, 2025